Starting Ozempic: What to Expect

See if you qualify — 5-minute assessment →
Reviewed by a licensed clinician · The Nouri Promise: a full refund in your first 30 days on the 3-month or 6-month plan · Cancel anytime

At a glance: what to expect week by week

Phase	What to expect	Management tip
Week 1–2 (starting dose)	Reduced appetite; possibly mild nausea or fatigue	Small, bland meals; stay hydrated; eat slowly
Each dose increase	GI side effects can return for a few days to ~2 weeks	Ask to hold the step if it's rough; don't skip meals
Weeks 4–8	Body adjusts; side effects often ease at a steady dose	Keep protein intake high; stay consistent
Months 2–6+	Weight loss builds; side effects usually milder or gone	Focus on protein, movement, and sleep

Side-effect patterns are drawn from trials of FDA-approved branded medications and are averages — individual experience varies. Information is current as of June 2026.

Why GI side effects happen on semaglutide

GLP-1 receptor agonists like semaglutide (the active ingredient in Ozempic and Wegovy) work partly by slowing gastric emptying — the rate at which your stomach passes food into the small intestine. This is part of why appetite decreases, but it's also the reason nausea, constipation, and other GI effects occur, especially when the dose is new or recently increased. The titration schedule in the Wegovy FDA prescribing label starts at 0.25 mg/week for four weeks precisely to give the GI tract time to adapt before increasing.

In the STEP 1 trial (Wilding et al., NEJM 2021) — which studied semaglutide 2.4 mg/week, the weight-management dose — nausea was the most common side effect but was predominantly mild-to-moderate and transient. These findings relate to the branded medication studied in the trial, not to compounded semaglutide.

Your first week on Ozempic

You'll start at a low introductory dose — it is not the full therapeutic strength. Many people notice reduced appetite and quieter "food noise" within the first week or two, sometimes accompanied by mild nausea. Significant weight changes aren't expected this early; the first weeks are primarily about your body adjusting to the medication.

Practical tips for week one: eat small meals, avoid fatty or spicy foods that can amplify nausea, stay well-hydrated, and take the injection at a consistent time each week. For nausea specifically, see the Ozempic nausea management guide.

What happens at each dose increase

Semaglutide is titrated upward in steps. Each increase can bring GI side effects back for a few days to about two weeks as your body adapts to the higher concentration — then they settle. This pattern tends to repeat at each step, and it is normal.

If a particular step is rough, your clinician can hold the dose or slow the schedule — this is expected and supported by clinical practice. Forcing through a poorly-tolerated step rarely speeds outcomes and often makes adherence harder. The NIDDK notes that starting low and titrating slowly is the standard approach for minimizing GI side effects with this class of medication.

What to expect over the months

By weeks 4–8, side effects often ease substantially at a steady dose. Once you're at a stable dose, many people report that nausea becomes rare or disappears entirely. Meaningful weight loss accrues over months, not weeks — the STEP 1 trial showed that participants lost weight steadily over 68 weeks of treatment. The STEP 4 study (Rubino et al., JAMA 2021) also found that continuing treatment maintained weight loss, while stopping led to regain — reinforcing that these medications work over the long term, not as a short burst.

For a full breakdown of how long individual side effects last, see how long Ozempic side effects last. For nausea and constipation specifically, the dedicated guides (nausea and constipation) cover management strategies in detail.

Managing side effects day to day

Most GI side effects improve with straightforward adjustments. Eating small, protein-rich meals — rather than skipping meals entirely — helps the stomach adapt. Staying hydrated matters more than it sounds: nausea and reduced appetite can both contribute to inadequate fluid intake. For practical food strategies that reduce GI discomfort, see what to eat on a GLP-1.

Timing the weekly injection in the evening can help with nausea — mild symptoms during sleep matter less than symptoms during a workday. If constipation is a persistent issue, dietary fiber and hydration are first-line approaches; the constipation guide covers this in more detail.

When to contact your clinician

GLP-1 medications carry a boxed warning for thyroid C-cell tumors; they are contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). This is why the initial clinician review — before any prescription is issued — screens for these and other contraindications. The Zepbound FDA prescribing label and the FDA's human drug compounding guidance provide additional regulatory context on this class.

How Nouri supports your titration

The single biggest factor in managing GLP-1 side effects is slow dose titration — starting low and increasing gradually, with the flexibility to hold a step when needed. Nouri includes unlimited care-team access so you can slow your titration, flag rough patches, and adjust your plan without waiting for a scheduled appointment. The program also includes a nutrition plan built around the GI side effects — small, protein-forward meals that support adherence during the adjustment phase.

Nouri's compounded semaglutide starts at $120/month on the 6-month plan ($720 every 6 months); $145/month on the 3-month plan ($435); or $175/month billed monthly. Compounded tirzepatide starts at $175/month on the 6-month plan. The program includes the compounded GLP-1 medication (when prescribed), nutrition planning, and fitness programming — any dose, same price. Compounded GLP-1 medications are not FDA-approved and are not the same as, or therapeutically equivalent to, branded products like Wegovy, Ozempic, Zepbound, or Mounjaro.

The Nouri Promise: if you're not satisfied in your first 30 days, you get a full refund — available on the 3-month and 6-month plans.

Start your 5-minute assessment →
Reviewed by a licensed clinician · 30-day full refund on 3-month and 6-month plans · Cancel anytime

Not sure if you qualify?

GLP-1 prescriptions have eligibility criteria — BMI thresholds and medical history are reviewed by a licensed clinician before any medication is prescribed. For a plain-language overview of who typically qualifies, see do you qualify for a GLP-1? and how online GLP-1 programs work. Not everyone who applies will qualify, and the Nouri clinician review determines appropriateness for each individual.

Related side-effect guides

• Ozempic / Semaglutide Side Effects: Complete Guide — the full hub
• How Long Do Ozempic Side Effects Last?
• Ozempic Nausea: How to Manage It
• Ozempic Constipation: Causes and Relief
• Serious Ozempic Side Effects and Warnings

Frequently asked questions

What should I expect the first week on Ozempic?

A low starting dose, reduced appetite (and quieter "food noise"), and possibly mild nausea. Significant weight changes aren't expected in week one — the early weeks are mostly about your body adjusting to the medication.

What happens after your first Ozempic injection?

Most people feel little immediately; over the first few days appetite often decreases and mild nausea can appear. Side effects, if any, are usually mild at the low starting dose and tend to ease within days.

When do Ozempic side effects start?

Often within the first days to first week of starting, and again for a few days to about two weeks after each dose increase, then they ease as the body adjusts.

What week is hardest on Ozempic?

Usually the days right after a dose increase, when your body is adjusting to a higher level. Slow titration and the option to hold a dose step with your clinician make these stretches easier. If a step is rough, ask about holding it before moving up.

How fast do you feel the effects of Ozempic?

Appetite changes are often noticed within the first week. GI side effects, if they occur, tend to appear in the first days after starting or after a dose increase. Meaningful weight changes build over months of consistent treatment.

What should I expect starting Wegovy or Mounjaro?

The same start-low-go-slow titration applies: a low introductory dose, reduced appetite, and possibly mild GI side effects that spike after each dose increase and then ease. Weight loss in the STEP 1 (Wegovy) and SURMOUNT-1 (Mounjaro/Zepbound) trials built steadily over months — results were from the branded medications in those studies, not from compounded products.

Sources & references

1. Wilding et al., "Once-Weekly Semaglutide in Adults with Overweight or Obesity" (STEP 1), NEJM 2021 — Tier 1
2. Rubino et al., "Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance" (STEP 4), JAMA 2021 — Tier 1
3. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Prescription Medications to Treat Overweight and Obesity — Tier 1
4. Wegovy FDA Prescribing Label — adverse reactions and dosing titration schedule — Tier 1
5. Zepbound FDA Prescribing Label — adverse reactions and contraindications — Tier 1
6. FDA: Human Drug Compounding — regulatory framework for 503A compounding pharmacies — Tier 1
7. GLP-1 titration and what to expect (Cleveland Clinic Health Essentials) — Tier 3

Side-effect rates referenced above are from trials of FDA-approved branded medications. Information is current as of June 2026.

Medically reviewed by Amber Patel, MD. Nouri content is reviewed by licensed clinicians and updated as guidance changes.

This article is general information, not individual medical advice — talk to your clinician about your specific symptoms and circumstances, and seek urgent care for the red-flag symptoms described above. Side-effect patterns referenced here are drawn from clinical trials of FDA-approved branded medications (Wegovy, Zepbound, Ozempic, Mounjaro); compounded semaglutide and compounded tirzepatide were not studied in these trials, are not FDA-approved, and are not the same as, or therapeutically equivalent to, the brand-name drugs. GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Ozempic®, Wegovy®, and Rybelsus® are registered trademarks of Novo Nordisk; Mounjaro® and Zepbound® are registered trademarks of Eli Lilly; Nouri is not affiliated with these companies. Information is current as of June 2026.